China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) traded at $0.25 at last check on Wednesday, Sep 16, making a downturn move of -1.53% on its previous day’s price.

Looking at the stock we see that its previous close was $0.26 and the beta (5Y monthly) reads 0 with the day’s price range being $0.2431 – 0.2588. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, SXTC has a high of $2.39 and a low of $0.22. The company’s stock has gained about -30.88% over that past 30 days.

There have been no upward or downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the SXTC stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Let’s briefly compare China (SXTC) stock to its peers. We find that today’s price change of -1.53% and -88.79% over the past 12 months for SXTC competes that of Zoetis Inc Cl A (ZTS), which has seen its stock price rise 0.66% in the latest trading session and is +35.64% over the last one year. Another of its peers Takeda Pharmaceutical Co. Ltd (TAK) has climbed 2.12% today, and is +6.29% up over the past year, while Catalent Inc (CTLT) is also down -1.53% yet its price remains in the red at -88.79% over the same period. Zoetis has a P/E ratio of 48 compared to China’s 0 and Takeda’s 22.7. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 0.47% and 0.77%, respectively, in early deals.

Coming back to China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC), we note that the average 3-month trading volume was 5.84 Million, while that of the preceding 10-day period stands at 4.05 Million. Current shares outstanding are 27.73 Million.

According to data from Thomson Reuters, insiders hold 51.21% of the company’s shares while institutions hold 15.24%. The data shows that short shares as of August 30, 2020, stood at 140.49 Million at a short ratio of 0.04. This represents a 0.23% Short interest in Shares outstanding on August 30, 2020. Shares short rose in August from the previous month at 137.03 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -68.83% down in year-to-date price movement.